274 filings
8-K
RSLS
ReShape Lifesciences Inc.
10 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:57pm
8-K
RSLS
ReShape Lifesciences Inc.
9 Apr 24
Changes in Registrant's Certifying Accountant
7:32pm
8-K
RSLS
ReShape Lifesciences Inc.
4 Apr 24
Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX
11:12am
10-K
2023 FY
RSLS
ReShape Lifesciences Inc.
Annual report
1 Apr 24
5:18pm
8-K
RSLS
ReShape Lifesciences Inc.
26 Feb 24
Submission of Matters to a Vote of Security Holders
4:19pm
8-K
f8k6quv
18 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:38pm
8-K
jvf5w mxr1
29 Nov 23
Entry into a Material Definitive Agreement
4:05pm
8-K
quvfyjc020pl
8 Nov 23
Third Quarter Core Operating Expenses Reduced 37% Compared to Third Quarter of 2022
5:44pm
8-K
fjc988opp1wq2qvk
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:42pm
8-K
3gh 3k601chg
5 Oct 23
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
4:05pm
424B4
o81ebg0au i37
3 Oct 23
Prospectus supplement with pricing info
9:23am
EFFECT
crq6cr6kj3b5rvjz027
2 Oct 23
Notice of effectiveness
12:15am
CORRESP
zczq04fv13q wpgmuep
28 Sep 23
Correspondence with SEC
12:00am
8-K
sjyonc
22 Sep 23
ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System
4:02pm
UPLOAD
9lbdwo74d0ag
30 Aug 23
Letter from SEC
12:00am